Mortality profile of Covid-19 patients in the municipality of Cascavel in the years 2020 and 2021
DOI:
https://doi.org/10.33448/rsd-v11i16.37937Keywords:
SARS-CoV-2 infection; Pandemic; Mortality determinants.Abstract
Covid-19, a viral disease caused by SARS-CoV-2, reached pandemic status in March 2020. Since then, epidemiological studies have been essential to comprehend the profile of patients who develop serious complications and have higher fatality rates. Therefore, this study sought to understand the mortality profile of the disease in the municipality of Cascavel and concluded that deaths are concentrated in the male population, with emphasis on retirees with chronic comorbidities, mainly Systemic Arterial Hypertension and Diabetes Mellitus. These results were consistent with the literature developed from similar works. Furthermore, this work proposed to present justifications that explain this predominant mortality profile in Cascavel.
References
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/s0140-6736(20)30211-7
Chu, D. K. W., Pan, Y., Cheng, S. M. S., Hui, K. P. Y., Krishnan, P., Liu, Y., Ng, D. Y. M., Wan, C. K. C., Yang, P., Wang, Q., Peiris, M., & Poon, L. L. M. (2020). Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clinical Chemistry, 66(4), 549–555. https://doi.org/10.1093/clinchem/hvaa029
de Arimateia Batista Araujo-Filho, J., Valente Yamada Sawamura, M., Nathan Costa, A., Guido Cerri, G., & Higa Nomura, C. (2020). COVID-19 pneumonia: what is the role of imaging in diagnosis? Jornal Brasileiro de Pneumologia, 46(2), Artigo e20200114-e20200114. https://doi.org/10.36416/1806-3756/e20200114
Duarte, P. M. (2020). COVID-19: Origem do novo coronavirus. Brazilian Journal of Health Review, 3(2), 3585–3590. https://doi.org/10.34119/bjhrv3n2-187
Eastin, C., & Eastin, T. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. The Journal of Emergency Medicine, 58(4), 711–712. https://doi.org/10.1016/j.jemermed.2020.04.004
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C., Colli, M. L., Marchetti, P., Mathieu, C., Eizirik, D. L., Sebastiani, G., & Dotta, F. (2020). SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature. Frontiers in Endocrinology, 11. https://doi.org/10.3389/fendo.2020.596898
Fredrich, V. C. R., Nasr, A. M. L. F., Champion, L., Mello, T. P. d. C., Silva, J. V. A. d., Ziak, M. L., Bellizzi, A. M., Lopes, M. G. D., Junior, N. W., & Preto, C. A. G. (2020). Perfil de óbitos por Covid-19 no Estado do Paraná no início da pandemia: estudo transversal. Revista de Saúde Pública do Paraná, 3(Supl.). https://doi.org/10.32811/25954482-2020v3sup1p62
Hallal, P. C. (2020). Worldwide differences in COVID-19-related mortality. Ciência & Saúde Coletiva, 25(suppl 1), 2403–2410. https://doi.org/10.1590/1413-81232020256.1.11112020
He, F., Deng, Y., & Li, W. (2020). Coronavirus disease 2019: What we know? Journal of Medical Virology, 92(7), 719–725. https://doi.org/10.1002/jmv.25766
Hu, B., Guo, H., Zhou, P., & Shi, Z.-L. (2020). Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-020-00459-7
Lake, M. A. (2020). What we know so far: COVID-19 current clinical knowledge and research. Clinical Medicine, 20(2), 124–127. https://doi.org/10.7861/clinmed.2019-coron
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis, 10(2), 102–108. https://doi.org/10.1016/j.jpha.2020.03.001
Ministério da Saúde. (2022). Plano Nacional de Operacionalização da Vacinação Contra A Covid-19 (2ª ed.). Editora MS. http://bvsms.saude.gov.br/bvs/publicacoes/plano_nacional_operacionalizacao_vacinacao_covid19.pdf
Muhamad, S.-A., Ugusman, A., Kumar, J., Skiba, D., Hamid, A. A., & Aminuddin, A. (2021). COVID-19 and Hypertension: The What, the Why, and the How. Frontiers in Physiology, 12. https://doi.org/10.3389/fphys.2021.665064
O. de Almeida, J., T. de Oliveira, V. R., Lucas dos S. Avelar, J., Simões Moita, B., & Moreira Lima, L. (2020). COVID-19: Physiopathology and Targets for Therapeutic Intervention. Revista Virtual de Química, 12(6), 1464–1497. https://doi.org/10.21577/1984-6835.20200115
Organização Mundial da Saúde. (2020). Coronavirus disease 2019 (COVID-19): situation report, 51. Organização Mundial da Saúde. https://apps.who.int/iris/handle/10665/331475
Pal, R., & Bhansali, A. (2020). COVID-19, diabetes mellitus and ACE2: The conundrum. Diabetes Research and Clinical Practice, 162, 108132. https://doi.org/10.1016/j.diabres.2020.108132
Pinheiro, T. M. D. ., Oliveira, E. de S. ., & Morais, A. C. L. N. de . (2021). Tendências na incidência e mortalidade do SARS-COV-2 no Estado do Ceará: impacto das comorbidades. Revista de Casos e Consultoria, 12(1), e23520. https://periodicos.ufrn.br/casoseconsultoria/article/view/23520
Rafael, R. D. M. R., Neto, M., Carvalho, M. M. B. d., David, H. M. S. L., Acioli, S., & Faria, M. G. d. A. (2020). Epidemiologia, políticas públicas e pandemia de Covid-19: o que esperar no Brasil? [Epidemiology, public policies and Covid-19 pandemics in Brazil: what can we expect?] [Epidemiologia, políticas públicas y la pandémia de Covid-19 en Brasil: que podemos esperar?]. Revista Enfermagem UERJ, 28, Artigo e49570. https://doi.org/10.12957/reuerj.2020.49570
Schurz, H., Salie, M., Tromp, G., Hoal, E. G., Kinnear, C. J., & Möller, M. (2019). The X chromosome and sex-specific effects in infectious disease susceptibility. Human Genomics, 13(1). https://doi.org/10.1186/s40246-018-0185-z
Sharma, K., Koirala, A., Nicolopoulos, K., Chiu, C., Wood, N., & Britton, P. N. (2021). Vaccines for COVID-19: Where do we stand in 2021? Paediatric Respiratory Reviews, 39, 22–31. https://doi.org/10.1016/j.prrv.2021.07.001
Silva Reis, A. A., & Santos, R. d. S. (2020). O padrão ouro no diagnóstico molecular na COVID19: O que sabemos sobre a soberania deste método?. Brazilian Journal of Health Review, 3(3), 5986–5992. https://doi.org/10.34119/bjhrv3n3-157
Sousa, G. O., Sales, B. N., Rodrigues, A. M. X., Rocha, G. M. d. M., & Oliveira, G. A. L. d. (2020). Evolução epidemiológica da COVID-19 no Brasil e no mundo. Research, Society and Development, 9(7), Artigo e630974653. https://doi.org/10.33448/rsd-v9i7.4653
Souza, L. G. ; Randow, R. ; Siviero, P. C. L. (2020). Reflexões em tempos de COVID-19: diferenciais por sexo e idade. Comunicação em Ciências Da Saúde (Impresso),31 (1), 75-83.
Sun, Y.-J., Feng, Y.-J., Chen, J., Li, B., Luo, Z.-C., & Wang, P.-X. (2020). Clinical Features of Fatalities in Patients With COVID-19. Disaster Medicine and Public Health Preparedness, 1–3. https://doi.org/10.1017/dmp.2020.235
Taneda, M. (2020). Características clínicas e radiológicas, evolução clínica e epidemiologia da infecção por SARS-CoV-2. Brazilian Journal of Development, 6(4), 20107–20116. https://doi.org/10.34117/bjdv6n4-256
Tavares, C. d. A. M., Avelino-Silva, T. J., Benard, G., Cardozo, F. A. M., Fernandes, J. R., Girardi, A. C. C., & Jacob, W. (2020). Alterações da ECA2 e Fatores de Risco para Gravidade da COVID-19 em Pacientes com Idade Avançada. Arquivos Brasileiros de Cardiologia, 115(4), 701–707. https://doi.org/10.36660/abc.20200487
Toassi, F.C.R, & Petry, P.C. (2021). Metodologia Científica aplicada à área da Saúde (2a ed). Porto Alegre, Brasil: Editora da UFRGS. https://lume.ufrgs.br/bitstream/handle/10183/218553/001123326.pdf?sequence=1&isAllowed=y
Velavan, T. P., & Meyer, C. G. (2020). The COVID‐19 epidemic. Tropical Medicine & International Health, 25(3), 278–280. https://doi.org/10.1111/tmi.13383
Yang, L., Liu, S., Liu, J., Zhang, Z., Wan, X., Huang, B., Chen, Y., & Zhang, Y. (2020). COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduction and Targeted Therapy, 5(1). https://doi.org/10.1038/s41392-020-00243-2
Zhang, J.-j., Dong, X., Cao, Y.-y., Yuan, Y.-d., Yang, Y.-b., Yan, Y.-q., Akdis, C. A., & Gao, Y.-d. (2020). Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 75(7), 1730–1741. https://doi.org/10.1111/all.14238
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Mariana Piano Vargas; Marcelo Rodrigo Caporal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
